London: A new Alzheimer`s drug can slow the pace of memory loss by 34 percent in those with the disease, two separate trials of the drug have found. Combined results from two trials showed the drug, called solanezumab, slows the speed of mental decline by a third in those with mild-to-moderate disease.A pharmaceutical firm which developed the drug has claimed that it helps clear the protein `plaques` thought to cause Alzheimer`s. Researchers in two trials found that the drug slowed the pace of cognitive decline by 34 per cent, over an 18-month period, compared to those given a placebo. Rachelle Doody, professor of neurology at Baylor College of Medicine, who was involved in the research, described the finding as "encouraging".
US: Meningitis outbreak kills 8, 13,000 given steroid shots
New `barcode` blood test can pick out aggressive prostate cancer